Benzinga··Vandana SinghPfizer's Dual Cancer Wins Boost Stock as Prostate, Breast Trials Succeed
Pfizer shares rise on Phase 3 prostate cancer trial win and Phase 2 breast cancer success, validating its oncology pipeline and signaling near-term regulatory catalysts.
PFEbreast cancerPhase 3 trial